Tag Archives: nanotechnology-based dietary supplements

Took a look at nano vitamin webcast

There was an event called Nanotech and Your Daily Vitamins based on a newly released report called A Hard Pill to Swallow January 14, 2009, at the Project on Emerging Nanotechnologies (PEN). The event has been posted as a webcast. I watched it a few weeks ago and finally got a chance to review the report today. The most disconcerting thing about the affair is how little information anyone has about nanoscale ingredients in dietary supplements and the speed at which these products are proliferating. From the report’s introduction,

[When we started] there were 11 dietary supplements on the market that claimed to use nanoscale ingredients, such as calcium, magnesium and silver. Now less than two years later, our research has found indications that the number of manufacturer-identified dietary supplementary products claiming to use nanoscale ingredients has more than tripled to over 40 products.

I imagine that not every manufacturer wants to admit that they’re using nanoscale ingredients (so it makes me wonder how many more of these products there are) or even agrees that the ingredients should be considered as something unique. As a matter of fact, in a report of this kind I’d expect to see a definition for what constitutes a nanoscale ingredient. Overall, the report and the webcast where the authors discussed their findings were a disappointment to me. My impression is that the authors did not have a good grasp of the topic. If you’re curious about their findings and their recommendations, you can find the report and the webcast here, just click in the sidebar on the right.

Inspiration for a new approach to risk regulation for nanotechnology

I’m getting into the home stretch now regarding the ‘Risk Management Principle for Nanotechnology’ article. After dealing with the ‘classic’ risk principles and the newer precautionary principles, the authors (Marchant, Sylvester, and Abbott) unveil a theory for their proposed ‘new principles’. The theory is based on work by I. Ayres and J. Braithwaite on something they call, ‘Responsive Regulation’. Briefly, they suggest avoiding the regulation/deregulation debate in favour of a flexible regulatory approach where a range of strategies are employed.

With this tool kit [range of strategies] in hand, regulators can play a tit-for-tat strategy: they allow firms to self-regulate so long as the firms reciprocate with responsible action; if instead some firms act opportunistically, regulators respond to the defectors with appropriate penalties and more stringent regulation. p. 52 (Nanoethics, 2008, vol. 2 pp. 43-60

There are some difficulties associated with this approach but that is being saved for my next posting in this series.

The Project on Emerging Nanotechnologies has two events coming up. ‘Synthetic Biology: Is Ethics a Showstopper?’ on Thursday, January 8, 2009 from 12:30 pm – 1:30 pm (EST). For information on location (you have to RSVP) or how to attend via webcast (no RSVP required), check here. The other event is called, ‘Nanotech and Your Daily Vitamins; Barriers to Effective FDA Regulation of Nanotechnology-Based Dietary Supplements’ and will be held on Thursday, January 15 (?) from 9:30 am – 10:30 am (EST). The date listed on their website and in their invitation is January 14, which is incorrect. I imagine they’ll correct either the date or date soon. For more details about the event itself, the physical location (If you’re planning to go, please RSVP), or the webcast directions (RSVP) not required) please check here.